molsidomine has been researched along with Kidney Failure, Chronic in 1 studies
Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Excerpt | Relevance | Reference |
---|---|---|
"To determine whether ESRD causes oxidative stress, we measured basal levels of plasma F2-isoprostanes as a marker of lipid peroxidation in vivo, and peroxynitrite-stimulated formation of F2-isoprostanes, as a marker of the oxidizibility of plasma lipids in vitro, before and after routine hemodialysis." | 1.32 | Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients. ( Buoncristiani, U; Canestrari, F; Davenport, A; Ferraro, B; Frei, B; Galli, F; Kingdon, E; Moore, KP; Rice-Evans, C, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferraro, B | 1 |
Galli, F | 1 |
Frei, B | 1 |
Kingdon, E | 1 |
Canestrari, F | 1 |
Rice-Evans, C | 1 |
Buoncristiani, U | 1 |
Davenport, A | 1 |
Moore, KP | 1 |
1 other study available for molsidomine and Kidney Failure, Chronic
Article | Year |
---|---|
Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; F2-Isoprostanes; Female; Humans; Kidney Failure, Chronic; Lipids; Ma | 2003 |